GlassScriptPhysician profile
Dylan Gallacher
NPI 1679956668
$8,508.64
in general payments reported to CMS, 2019-2025
52 companies · $1,702 in 2025
The $1,702 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,694 · 2022: $2,825 · 2023: $33.45 · 2024: $1,254 · 2025: $1,702.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,073 · Travel and Lodging: $1,042 · Food and Beverage: $836 · Education: $40.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,072.50 |
| Travel and Lodging | $1,041.62 |
| Food and Beverage | $835.57 |
| Education | $40.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $1,322.00 | 2022-2025 | Vns Therapy |
| Abbvie INC. | $1,127.90 | 2021-2025 | |
| Eisai INC. | $740.46 | 2021-2025 | |
| Janssen Scientific Affairs, LLC | $612.50 | 2024 | |
| Biogen, INC. | $457.08 | 2021-2022 | |
| Novo Nordisk INC | $433.87 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $427.68 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $345.76 | 2021 | |
| Lilly USA, LLC | $340.03 | 2021-2024 | Kisunla |
| Ucb, INC. | $213.81 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $206.25 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $184.10 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $164.22 | 2021-2022 | |
| Neurelis, INC. | $159.29 | 2022-2025 | Valtoco |
| Bayer Healthcare Pharmaceuticals INC. | $146.71 | 2021-2022 |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dylan Gallacher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.